FDA warning letter
Issue date
2 Aug 2019
Issuing office
Division of Pharmaceutical Quality Operations I
Posted date
10 Sept 2019
Subject
Drug Product/Adulterated
Products & Services
Drugs
Headquarters
Sites
Issue date
Issuing office
Posted date
Subject
Products & Services